Mallory Loflin
Mallory Loflin
VA Center of Excellence for Stress and Mental Health
Verified email at
Cited by
Cited by
Labeling accuracy of cannabidiol extracts sold online
MO Bonn-Miller, MJE Loflin, BF Thomas, JP Marcu, T Hyke, R Vandrey
Jama 318 (17), 1708-1709, 2017
A New Method of Cannabis Ingestion: The Dangers of Dabs?
M Loflin, M Earleywine
Addictive Behaviors, 2014
Cannabinoids as therapeutic for PTSD
M Loflin, K Babson, M Bonn-Miller
Current Opinion in Psychology 14, 78-83, 2017
Subtypes of attention deficit-hyperactivity disorder (ADHD) and cannabis use
M Loflin, M Earleywine, J De Leo, A Hobkirk
Substance use & misuse 49 (4), 427-434, 2014
Medicinal versus recreational cannabis use: Patterns of cannabis use, alcohol use, and cued-arousal among veterans who screen positive for PTSD
M Loflin, M Earleywine, M Bonn-Miller
Addictive Behaviors, 2017
No smoke, no fire: what the initial literature suggests regarding vapourized cannabis and respiratory risk
M Loflin, M Earleywine
Canadian Journal of Respiratory Therapy: CJRT= Revue Canadienne de la …, 2015
Cannabis and cannabinoid drug development: evaluating botanical versus single molecule approaches
MO Bonn-Miller, MA ElSohly, MJE Loflin, S Chandra, R Vandrey
International Review of Psychiatry 30 (3), 277-284, 2018
Assessment of the validity of the CUDIT-R in a subpopulation of cannabis users
M Loflin, K Babson, K Browne, M Bonn-Miller
The American journal of drug and alcohol abuse 44 (1), 19-23, 2018
Don’t wake and bake: morning use predicts cannabis problems
M Earleywine, R Luba, MN Slavin, S Farmer, M Loflin
Addiction Research & Theory 24 (5), 426-430, 2016
Curious Consequences of Cannabis Prohibition
M Earleywine, M Loflin
Alb. Gov't L. Rev. 6, 438-663, 2013
The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda
MJE Loflin, BD Kiluk, MA Huestis, WM Aklin, AJ Budney, KM Carroll, ...
Drug and alcohol dependence, 107993, 2020
Placebo effects of edible cannabis: Reported intoxication effects at a 30-minute delay
MJE Loflin, M Earleywine, S Farmer, M Slavin, R Luba, M Bonn-Miller
Journal of Psychoactive Drugs 49 (5), 393-397, 2017
The case for medical marijuana: an issue of relief.
M Loflin, M Earleywine
Drug and alcohol dependence 149, 293, 2015
A cross-sectional examination of choice and behavior of veterans with access to free medicinal cannabis
MJE Loflin, K Babson, J Sottile, SB Norman, S Gruber, MO Bonn-Miller
The American journal of drug and alcohol abuse 45 (5), 506-513, 2019
Navigating Blind in the Green Rush: Clinical Considerations and Harm Reduction Practices for Cannabis
BN Meffert, DM Morabito, MK Mosich, MJ Loflin, J Sottile, AJ Heinz
Current Drug Research Reviews Formerly: Current Drug Abuse Reviews 11 (1), 3-11, 2019
Do I smell pot? A trial of an alternative paradigm of olfactory cue-reactance to marijuana
MJ Loflin, M Earleywine
Addiction Research & Theory 22 (3), 210-217, 2014
A Cross-Sectional and Prospective Comparison of Medicinal Cannabis Users and Controls on Self-Reported Health
NJ Schlienz, R Scalsky, EL Martin, H Jackson, J Munson, JC Strickland, ...
Cannabis and Cannabinoid Research, 2020
Aversiveness and Meaningfulness of Uncomfortable Experiences with Edible Cannabis
S Farmer, MN Slavin, MJE Loflin, R Luba, M Earleywine
Journal of psychoactive drugs 51 (5), 413-420, 2019
Craving and Cannabis: A Potential Paradox
MJ Loflin, M Earleywine
Handbook of Cannabis and Related Pathologies, 317-325, 2017
Burden of cannabis use and disorder in the US veteran population: psychiatric comorbidity, suicidality, and service utilization
ML Hill, BM Nichter, SB Norman, M Loflin, RH Pietrzak
Journal of affective disorders, 2020
The system can't perform the operation now. Try again later.
Articles 1–20